Tadalafil 5 mg once daily for the treatment of erectile dysfunction during a 6-month observational study (EDATE): impact of patient characteristics and comorbidities

BACKGROUND: To explore the impact of patient-characteristics and relevant comorbidities on treatment continuation rates, effectiveness, and satisfaction in patients with erectile dysfunction (ED) who started or switched to tadalafil 5 mg once daily (TAD-OaD) at baseline. METHODS: In the EDATE observ...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMC Urol
Autors principals: Hatzichristou, Dimitrios, d’Anzeo, Gianluca, Porst, Hartmut, Buvat, Jacques, Henneges, Carsten, Rossi, Andrea, Hamidi, Karim, Büttner, Hartwig
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2015
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4643510/
https://ncbi.nlm.nih.gov/pubmed/26563171
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12894-015-0107-5
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars